Research ArticleLaboratory Studies
A Biological Method to Evaluate Bifunctional Chelating Agents to Label Antibodies with Metallic Radionuclides
Yasushi Arano, Takahiro Mukai, Takashi Uezono, Kouji Wakisaka, Hiroshi Motonari, Hiromichi Akizawa, Yuuko Taoka and Akira Yokoyama
Journal of Nuclear Medicine May 1994, 35 (5) 890-898;
Yasushi Arano
Takahiro Mukai
Takashi Uezono
Kouji Wakisaka
Hiroshi Motonari
Hiromichi Akizawa
Yuuko Taoka


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
A Biological Method to Evaluate Bifunctional Chelating Agents to Label Antibodies with Metallic Radionuclides
Yasushi Arano, Takahiro Mukai, Takashi Uezono, Kouji Wakisaka, Hiroshi Motonari, Hiromichi Akizawa, Yuuko Taoka, Akira Yokoyama
Journal of Nuclear Medicine May 1994, 35 (5) 890-898;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Copolymer-Based Hepatocyte Asialoglycoprotein Receptor Targeting Agent for SPECT
- Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients: Comparison of Radiation Dosimetry for 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-Tetraacetic Acid (DOTA)-Peptide versus 2IT-DOTA Monoclonal Antibody Linkage for RIT
- Detection of Experimental Autoimmune Myocarditis in Rats by 111In Monoclonal Antibody Specific for Tenascin-C
- Pharmacokinetic Analysis of in Vivo Disposition of Succinylated Proteins Targeted to Liver Nonparenchymal Cells via Scavenger Receptors: Importance of Molecular Size and Negative Charge Density for in Vivo Recognition by Receptors
- Development of a Hepatocyte-Specific Prostaglandin E1 Polymeric Prodrug and Its Potential for Preventing Carbon Tetrachloride-Induced Fulminant Hepatitis in Mice
- Targeted Delivery and Improved Therapeutic Potential of Catalase by Chemical Modification: Combination with Superoxide Dismutase Derivatives
- Chemical Design of Radiolabeled Antibody Fragments for Low Renal Radioactivity Levels